The SURPASS phase III clinical trials for tirzepatide involve more than 13,000 patients with T2D and aim to gain a better understanding of its efficacy and safety (ClinicalTrials.gov Identifier: NCT04255433)
Supplied as four separate lyophilized peptide powders (TB500, BPC157, GHK-CU, KPV)
The authors reported that BPC 157 significantly accelerated the outgrowth of tendon explants and amount-dependently increased the in vitro migration of tendon fibroblasts [2]
Some research suggests women may experience greater weight loss than men on semaglutide, and may also benefit from improved insulin sensitivity and cardiometabolic health, and possibly increased fertility
Another best practice is for the compounding pharmacy to periodically send a batch of received API out for third-party testing, to ensure sterility, potency, and lack of endotoxins and impurities